Galmed Pharmaceuticals Ltd. Recorded Big Gain

Tue, Sep 17, 2024 at 05:30 PM

Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ) shot up at $15.1, a gain of 290.2%. On Mon, Sep 16, 2024, GLMD:NASDAQ touched a New 2-Week Intraday High of $4.19. From Tue, Sep 03, 2024, the stock recorded 55.56% Up Days and 70.00% Green Days

The stock spiked on Wed, Aug 21, 2024 at $5.3 with a volume of 1M+.

About Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ)

Galmed Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of oral therapy for the treatment of liver diseases and cholesterol gallstones.

Top 10 Gainers:

Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ), 290.18%
Smith Micro Software, Inc. (SMSI:NASDAQ), 117.97%
BurgerFi International Inc (BFI:NASDAQ), 92.98%
IO Biotech Inc. (IOBT:NASDAQ), 53.51%
The Howard Hughes Corporation (HHH:NYSE), 45.45%
The Children's Place, Inc. (PLCE:NASDAQ), 42.51%
Neonode Inc. (NEON:NASDAQ), 35.15%
XCHG Limited (XCH:NASDAQ), 34.38%
TOYO Co. Ltd (TOYO:NASDAQ), 33.33%
REE Automotive Ltd. (REE:NASDAQ), 28.34%